DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20211705

A comparative study of efficacy of oral itraconazole, terbinafine and fluconazole: a clinical trial

Savita C. Koregol, Soumya R. Naik, Abhineetha Hosthota, Arati C. Koregol

Abstract


Background: Keeping in view the rising number of cases of dermatophyte infections and also poor response to topical drugs, this study was conducted with the intention to arrive at a conclusion regarding the best available systemic drug.

Methods: A total of 270 patients were selected for the study. 90 patients were assigned to each group under itraconazole, terbinafine & fluconazole.

Results: It was found that itraconazole was the most effective drug which led to a considerable decrease in erythema, peripheral spread, scaling and spread to other body sites. Next drug to be the most effective was terbinafine, which was followed by fluconazole.

Conclusions: We finally arrived at a conclusion that itraconazole is the most effective drug for all types of superficial fungal infections. It was followed by terbinafine & fluconazole in terms of drug effectiveness. Hence in this study we advocate the use of itraconazole as first line of drug in all patients of tinea infections.

 


Keywords


Itraconazole, Terbinafine, Tinea

Full Text:

PDF

References


Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65(10):2095-102.

Gupta AK, Chaudhry M, Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatol Clin. 2003;21(3):395-400.

Kovitwanichkanont T, Alvin C. Superficial fungal infections. Austral J Gen Pract. 2019;48(10):706-11.

Doncker PD, Pande S, Richarz U, Garodia N. Itraconazole: what clinicians should know? Indian J Drugs Dermatol. 2017;3(1):4-10.

Bhatia A, Kanish B, Badyal DK, Kate P, Choudhary S. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin – A prospective, randomized comparative study. Indian J Pharmacol. 2019;51(2):116-9.

Ellis D, Watson A. Systemic antifungal agents for cutaneous fungal infections. Aust Prescr. 1996;19:72-5.

Ely JW, Rosenfeld S, Stone MS. Diagnosis and management of tinea infections. Am Fam Physician. 2014;90(10):702-10.

Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016;7(2):77-86.

Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. Br J Dermatol. 2004;150(1):119-26.

Shakya N, Jha S, Dangol A, Shakya S, Shah A. Efficacy of Itraconazole Versus Terbinafine for the Treatment of Tineacruris. Med J Sri Bipendra Hosp. 2013;11(1):24-6.

Sultana R, Wahiduzzaman M. Emerging threat in antifungal resistance on superficial dermatophyte infection. Bangladesh Med J Khulna. 2019;51(1-2):21-4.

Singh S, Chandra U, Anchan VN, Verma P, Tilak R. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial. Br J Dermatol. 2020;183(3):840-6.

Ardeshna KP, Rohatgi S, Jerajani HR. Successful treatment of recurrent dermatophytosis with isotretinoin and itraconazole. Indian J Dermatol Venereol Leprol. 2016;82(5):579-82.

Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: An appraisal. Indian J Dermatol. 2017;62(3):227-36.